Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia

Clinical Chemistry

Volumn 53, Issue 7, 2007, Pages 1315-1322

  Ihenetu, Kenneth ^a,b   Qazzaz, Hassan M ^a   Crespo, Fabian ^a   Fernandez Botran, Rafael ^a   Valdes Jr , Roland ^a  

^a University of Louisville School of Medicine   (United States)

^b TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; DIGITALIS LIKE FACTOR; DIGOXIN; FAS LIGAND; OUABAIN; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA;

ADOLESCENT; APOPTOSIS; CARDENOLIDES; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; DIGOXIN; FAS LIGAND PROTEIN; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, T-CELL, ACUTE; LEUKOCYTES, MONONUCLEAR; MALE; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; RNA, MESSENGER; SAPONINS;

MAMMALIA; STROPHANTHUS GRATUS;

EID: 34347379512     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.082081     Document Type: Article

References (40)

1. Skou JC, Esmann M. The Na,K-ATPase. J Bioenerg Biomembr 1992;24:249-61.
2. Schoner W, Scheiner-Bobis G. Endogenous cardiac glycosides: hormones using the sodium pump as signal transduction. Semin Nephrol 2005;25:343-51.
3. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol Renal Physiol 1998;275:F633-50.
4. Stenvist B. Is digitalis a therapy for breast carcinoma? Oncol Rep 1999;6:493-6.
5. Haux J, Lam M, Marthinsen ABC, Strichert T, Lundgren S. Digitoxin in nontoxic concentrations induces apoptotic cell death in Jurkat T cells in vitro. Z Onkol/J Oncol 1999;31:14-20.
6. 2+ increases and apoptosis in androgen-independent, metastatic human prostrate adenocarcinoma cells. Cancer Res 2000;60:3807-12.
7. Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P. Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs 2001;12:475-83.
8. Qazzaz HM, Cao Z, Bolanowski DD, Clark BJ, Valdes R Jr. De novo biosynthesis of mammalian digitalis-like factors. Clin Chem 2004;50:469-70.
9. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Mandel F, Mathews WR, et al. Identification and characterization of ouabain-like compounds from human plasma. Proc Natl Acad Sci U S A 1991;88:6259-63.
10. + pumps [Review]. Miner Electrolyte Metab 1996;22:303-10.
11. Goto A, Yamada K, Hazama H, Uechara Y, Atarashi K, Hirata Y, et al. Ouabain-like compound in hypertension associated with ectopic corticotropin syndrome. Hypertension 1996;28:421-5.
12. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, et al. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A 1993;90:8189-93.
13. Lichstein D, Gati I, Samuelou S, Berson D, Rosenman Y, Landau L, et al. Identification of digitalis-like compounds in human caractous lenses. Eur J Biochem 1993;216:261-8.
14. Schneider R, Wray V, Nimtz M, Lehman WD, Kirch U, Antolovia R, et al. Bovine adrenals contain in addition to ouabain, a second inhibitor of sodium pump. J Biol Chem 1998;273:784-92.
15. +-transporting ATPase in prescreens for anti-cancer agents. Anticancer Drug Des 1995;10:177-87.
16. Qazzaz HMH, Valdes R Jr. Simultaneous isolation of endogenous digoxin-like immunoreactive factor (DLIF) and ouabain-like factor (OLF) from mammalian tissue. Arch Biochem Biophys 1996;328:193-200.
17. Schneider U, Schwark HU, Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 1969;19:621-6.
18. Lozzio BB, Lozzio CB. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk Res 1979;3:363-70.
19. Ihenetu K, Molleman A, Parsons M, Whelan C. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells. Eur J Pharmacol 2003;464:207-15.
20. Qazzaz HMH, El-Masri MA, Valdes R Jr. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells. Endocrinology 2000;141:3200-9.
21. Rosen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics Methods and Protocols. Totowa, NJ: Humana Press Inc., 2000:365-86.
22. Rose AM, Valdes R Jr. Understanding the sodium pump and its relevance to disease. Clin Chem 1994;40:1674-85.
23. + ions. J Biochem 1999;126:278-86.
24. Wasserstrom JA, Aistrup GL. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 2005;289:H1781-93.
25. +-ATPase in human lymphocytes activated with phytohemagglutinin. FEBS Lett 1993;316:37-40.
26. +-ATPase in human breast cancer cells. Mol Pharmacol 2005;67:929-36.
27. Watanabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem 1996;271:14067-72.
28. Watanabe M, Kawazoe N, Masuda Y, Navajo S, Nakaya K. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activations in human leukemia U937 cells. Cancer Res 1997;57:3097-100.
29. Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res 1995;19:549-56.
30. Williams SS, French JN, Gilbert M, Rangaswami AA, Walleczek J, Knox SJ. Bcl-2 overexpression results in enhanced capacitative calcium entry and resistance to SKF-96365-induced apoptosis. Cancer Res 2000;60:4358-61.
31. Askenasy N, Yolcu ES, Wang S, Shirwan H. Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection. Circulation 2003;107:1525-31.
32. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia reperfusion in vivo. Am J Physiol Heart Circ Physiol 2003;284:H456-63.
33. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005;55:178-94.
34. +-ATPase pump activityxorrelation with radiation-induced programmed cell death. J Cell Physiol 1997;171:299-304.
35. Martinez-Lorenzo MJ, Alava MA, Anel A, Pineiro A, Naval J. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 1996;89:511-7.
36. Liu J, Kuszynski CA, Baxter BT. Doxycycline induces Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes. Biochem Biophys Res Commun 1999;260:562-7.
37. Qazzaz HM, Jortani SA, Poole JM, Valdes R Jr. Evidence for presence of reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues. Clin Chem 1996;42:1092-9.
38. Yeh JH, Huang WJ, Kann SF, Wang PS. Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostrate cancer cells. J Urol 2001;166:1937-42.
39. Huang YT, Chueh SC, Teng CM, Guh GH. Investigation of ouabain-induced anticancer effect in human androgen independent prostrate cancer PC-3 cells. Biochem Pharmacol 2004;67:727-33.
40. Lin H, Juang JL, Wang PS. Involvement of cdk5/p25 in digoxin-triggered prostrate cancer cell apoptosis. J Biol Chem 2004;279:29302-7.